RUBY
Baillie Gifford & Co’s Rubius Therapeutics, Inc RUBY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,869,126
| Closed | -$838K | – | 486 |
|
|
2022
Q4 | $838K | Buy |
4,869,126
+15,353
| +0.3% | +$2.64K | ﹤0.01% | 276 |
|
|
2022
Q3 | $2.11M | Sell |
4,853,773
-52,305
| -1% | -$22.7K | ﹤0.01% | 261 |
|
|
2022
Q2 | $4.17M | Sell |
4,906,078
-1,393
| -0% | -$1.19K | ﹤0.01% | 243 |
|
|
2022
Q1 | $27M | Sell |
4,907,471
-23,388
| -0.5% | -$129K | 0.02% | 196 |
|
|
2021
Q4 | $47.7M | Buy |
4,930,859
+237,027
| +5% | +$2.29M | 0.03% | 191 |
|
|
2021
Q3 | $83.9M | Sell |
4,693,832
-1,190
| -0% | -$21.3K | 0.04% | 151 |
|
|
2021
Q2 | $115M | Buy |
4,695,022
+1,151
| +0% | +$28.1K | 0.06% | 146 |
|
|
2021
Q1 | $124M | Sell |
4,693,871
-16,190
| -0.3% | -$429K | 0.07% | 139 |
|
|
2020
Q4 | $35.7M | Buy |
4,710,061
+436,200
| +10% | +$3.31M | 0.02% | 180 |
|
|
2020
Q3 | $21.4M | Buy |
4,273,861
+19,129
| +0.4% | +$95.8K | 0.01% | 180 |
|
|
2020
Q2 | $25.4M | Sell |
4,254,732
-2,168
| -0.1% | -$13K | 0.02% | 165 |
|
|
2020
Q1 | $18.9M | Buy |
4,256,900
+5,430
| +0.1% | +$24.2K | 0.02% | 148 |
|
|
2019
Q4 | $40.4M | Buy |
4,251,470
+10,703
| +0.3% | +$102K | 0.04% | 134 |
|
|
2019
Q3 | $33.3M | Buy |
4,240,767
+6,085
| +0.1% | +$47.8K | 0.04% | 141 |
|
|
2019
Q2 | $66.6M | Buy |
4,234,682
+101,831
| +2% | +$1.6M | 0.07% | 112 |
|
|
2019
Q1 | $74.8M | Buy |
4,132,851
+76,655
| +2% | +$1.39M | 0.08% | 108 |
|
|
2018
Q4 | $65.2M | Buy |
4,056,196
+146,584
| +4% | +$2.36M | 0.08% | 106 |
|
|
2018
Q3 | $93.8M | Buy |
+3,909,612
| New | +$93.8M | 0.1% | 96 |
|